Haemonetics Corp. (HAE)
102.76
-0.31
(-0.30%)
USD |
NYSE |
Sep 01, 14:54
Haemonetics Total Long Term Debt (Quarterly) : 1.174B for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.174B |
| March 31, 2026 | 1.265B |
| December 31, 2025 | 1.225B |
| September 30, 2025 | 1.225B |
| June 30, 2025 | 1.225B |
| March 31, 2025 | 1.275B |
| December 31, 2024 | 1.225B |
| September 30, 2024 | 1.225B |
| June 30, 2024 | 1.224B |
| March 31, 2024 | 865.75M |
| December 31, 2023 | 870.58M |
| September 30, 2023 | 762.23M |
| June 30, 2023 | 764.95M |
| March 31, 2023 | 765.89M |
| December 31, 2022 | 766.78M |
| September 30, 2022 | 817.75M |
| June 30, 2022 | 769.99M |
| March 31, 2022 | 829.29M |
| December 31, 2021 | 777.18M |
| September 30, 2021 | 780.78M |
| June 30, 2021 | 784.37M |
| March 31, 2021 | 770.57M |
| December 31, 2020 | 309.78M |
| September 30, 2020 | 464.02M |
| June 30, 2020 | 528.26M |
| Date | Value |
|---|---|
| March 31, 2020 | 434.51M |
| December 31, 2019 | 426.15M |
| September 30, 2019 | 384.97M |
| June 30, 2019 | 450.98M |
| March 31, 2019 | 350.12M |
| December 31, 2018 | 343.82M |
| September 30, 2018 | 343.65M |
| June 30, 2018 | 347.88M |
| March 31, 2018 | 253.68M |
| December 31, 2017 | 270.17M |
| September 30, 2017 | 286.60M |
| June 30, 2017 | 303.04M |
| March 31, 2017 | 314.65M |
| December 31, 2016 | 336.27M |
| September 30, 2016 | 388.05M |
| June 30, 2016 | 399.71M |
| March 31, 2016 | 408.00M |
| December 31, 2015 | 427.11M |
| September 30, 2015 | 434.31M |
| June 30, 2015 | 431.85M |
| March 31, 2015 | 427.89M |
| December 31, 2014 | 428.75M |
| September 30, 2014 | 429.41M |
| June 30, 2014 | 430.94M |
| March 31, 2014 | 437.69M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Globus Medical, Inc. | 97.53M |
| Abbott Laboratories | 32.61B |
| AngioDynamics, Inc. | 9.66M |
| Alphatec Holdings, Inc. | 597.42M |
| AtriCure, Inc. | 72.53M |